BCDA
CAS No. 3252-36-6
BCDA( 5-bromo-4-chloroindoxyl acetate )
Catalog No. M24259 CAS No. 3252-36-6
BCDA is a chromogenic substrate of esterase. It is used to detect the activity of esterase.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 29 | In Stock |
|
| 25MG | 40 | In Stock |
|
| 50MG | 57 | In Stock |
|
| 100MG | 83 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 221 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBCDA
-
NoteResearch use only, not for human use.
-
Brief DescriptionBCDA is a chromogenic substrate of esterase. It is used to detect the activity of esterase.
-
DescriptionBCDA is a chromogenic substrate of esterase. It is used to detect the activity of esterase.
-
In Vitro——
-
In Vivo——
-
Synonyms5-bromo-4-chloroindoxyl acetate
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number3252-36-6
-
Formula Weight288.52
-
Molecular FormulaC10H7BrClNO2
-
Purity>98% (HPLC)
-
SolubilityEthanol:100 mg/mL (346.58 mM)
-
SMILESCC(Oc1c[nH]c(cc2)c1c(Cl)c2Br)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Thalidomide-O-amido-...
Thalidomide-O-amido-PEG2-C2-NH2 TFA is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and 2-unit PEG linker used in PROTAC technology.
-
α-Casein 90-95
α-Casein (90-95) is a peptide fragment of α-Casein.
-
MID-1
MID-1 is an inhibitor of MG53-IRS-1 (Mitsugumin 53-Insulin Receptor Substrate-1) interaction.?It disrupts molecular association of MG53 with IRS-1 and abolishes MG53-induced IRS-1 ubiquitination and degradation in skeletal muscle, leading to elevated IRS-1 expression level and increased insulin signaling and glucose uptake.
Cart
sales@molnova.com